Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Tunica Albuginea who wrote (2757)	11/21/1997 1:33:00 PM
From: Brian Malloy	Read Replies (1) \| Respond to of 23519

I welcome seeing your medically factual posts TA. However, we should not be too hard on the brokers <ggg>. Thanks to them, the market is at times less than efficient in appraising the value of VVUS. This simply provides those of us who know what the real deal is an opportunity to pick up shares and options at ridiculously deflated prices. Their ignorance puts money into our pockets <$$$>. Regrds, Brian

To: Tunica Albuginea who wrote (2757)	11/21/1997 2:09:00 PM
From: BigKNY3	Read Replies (2) \| Respond to of 23519

TA:<<.Brokers are not capable of analyzing medical data because of the lack of medical-technical background.>> TA: Most physicians are not capable of analyzing the market potential of a pharmaceutical product because of their lack of marketing and financial background in the healthcare industry. Kidding aside, if you follow Smith Barney, they have been very successful in their Big Pharma picks over the last 3 years... including a buy recommendation on Warner Lambert last January (the stock has increased about 90% since that call). But, I agree with you. I would not use their reports to make prescribing decisions...only investing decisions. Some brokers in Big Pharma have been very accurate in predicting the success of new products and probably use outside medical consultants (Merril Lynch does for sure). Others, such as Payne Webber (neutral in 1/97 on WLA,PFE,BMY, and LLY) are absolutely terrible in their Big Pharma recommendations. Best advice..Read as much as possible (including these Boards) and then make your own investing decision. Good investing! BigKNY3